Latest posts

A June 2021 review of early RECOVERY results for casirivimab and imdevimab in hospitalised COVID-19 patients. It explains the reported mortality benefit in patients without detectable antibodies, why that finding did not extend to the whole trial population, and the preliminary evidence available then.

A fictional glimpse of chest pain assessment in 2050. Rick Body follows Fiona through a future of personalised risk prediction, implanted diagnostics and virtual consultation, using medical fiction to explore how technology might change both care and the experience of illness.

Rick Body introduces St Emlyn's medical fiction series: imagined future scenarios intended to stretch how we think about healthcare. The launch post explains the idea behind Med-Fi and links to the first story, exploring chest pain assessment in the future.

How can a thunderstorm trigger a surge in asthma-like presentations? This 2021 overview explains the proposed role of fragmented pollen, recalls major outbreaks and considers awareness and emergency department preparedness, including presentations in people with hay fever but no previous asthma diagnosis.

Iain and Simon revisit the St Emlyn's blog in their May 2021 podcast round-up. The linked reading covers anaphylaxis, staff wellbeing, adult congenital heart disease, calcium in trauma, spontaneous coronary artery dissection and reporting hospital data after the Manchester Arena bombing.

A June 2021 look at the first RECOVERY results for aspirin in hospitalised COVID-19 patients. The review considers the absence of a demonstrated mortality benefit, the balance between bleeding and thrombotic events, and the limits of the early results.